Boehringer Ingelheim

About Boehringer Ingelheim

Boehringer Ingelheim is a global, research-driven pharmaceutical company founded in Germany in 1885. The company focuses on developing medicines for human health and animal health, with a strong emphasis on scientific research and long-term healthcare innovation.

Its human pharmaceutical portfolio includes treatments across several therapeutic areas. In diabetes care, Jardiance is one of its recognised brands, containing empagliflozin as its active ingredient. The company also offers Jardiance Met, a combination medicine containing empagliflozin and metformin hydrochloride.

At KwickPharmacy, users can explore available Boehringer Ingelheim medicines by brand name, active ingredient and strength. Reviewing these details helps users understand the differences between individual products and find the relevant product information before discussing treatment with a healthcare professional.

Popular Boehringer Ingelheim Medicines

Jardiance – Empagliflozin

Jardiance contains empagliflozin, an SGLT2 inhibitor used in the management of type 2 diabetes. It works by helping the kidneys remove more glucose through urine, which helps lower blood sugar levels.

Depending on the approved indication in the relevant country, empagliflozin may also be prescribed for certain people with heart failure or chronic kidney disease. Its suitability depends on the patient’s medical history, kidney function and other medicines.

Products listed in the available catalogue include:

• Jardiance 10 mg – Empagliflozin 10 mg

• Jardiance 25 mg – Empagliflozin 25 mg

The two strengths are not interchangeable without medical guidance. The appropriate strength and treatment plan should be determined by the prescribing healthcare professional.

Jardiance Met – Empagliflozin and Metformin

Jardiance Met combines empagliflozin with metformin hydrochloride for the management of type 2 diabetes when a combination treatment is appropriate. The two ingredients work in different ways: empagliflozin increases glucose removal through urine, while metformin helps reduce glucose production in the liver and improves the body's response to insulin.

Products listed in the available catalogue include:

• Jardiance Met 12.5 mg/500 mg – Empagliflozin 12.5 mg + metformin 500 mg

• Jardiance Met 12.5 mg/1000 mg – Empagliflozin 12.5 mg + metformin 1000 mg

The amount of metformin differs between these formulations. The right option depends on the patient's glucose control, tolerance, kidney function and existing treatment. Do not switch strengths or combine diabetes medicines without advice from a healthcare professional.

Understanding Empagliflozin and Metformin

Empagliflozin and metformin are both used in type 2 diabetes care, but they work through different mechanisms. Empagliflozin belongs to the SGLT2 inhibitor class, while metformin is a biguanide medicine. A clinician may prescribe one or both depending on the person's treatment needs.

These medicines are not intended to replace a balanced diet, physical activity or routine diabetes monitoring. Empagliflozin can increase the risk of dehydration and certain genital or urinary infections, and in rare cases may contribute to diabetic ketoacidosis. Metformin can cause digestive side effects and may not be suitable for some people with significant kidney problems. Patients should discuss existing medical conditions, other medicines and symptoms with their healthcare professional. Follow the prescribed instructions and do not adjust treatment based only on a blood glucose reading.

How to Choose the Right Boehringer Ingelheim Medicine

Start by checking the brand name, active ingredient, strength and formulation on the product page and packaging. Jardiance contains empagliflozin alone, whereas Jardiance Met contains empagliflozin with metformin. This difference matters when reviewing a prescription or comparing products.

For diabetes treatment, a healthcare professional considers blood glucose results, kidney function, other health conditions and the medicines already being taken. Do not use another person's medicine or change the prescribed strength without professional advice.

Purchase prescription medicines only through legitimate channels and follow the applicable prescription requirements. Keep the packaging and patient information leaflet available so the medicine can be checked if questions arise.